TOKYO -- Japanese beverage and pharmaceuticals group Kirin Holdings will spend roughly 7 billion yen ($66.8 million) in Thailand to produce sugars that increasingly are added to infant formula to mimic the components of mother's milk.
The group has developed technology to mass-produce human milk oligosaccharides, or HMOs, which are found naturally in breast milk and offer benefits including to the immune system.
